• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.
 

Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Options
  • Details
BORIS DOI
10.7892/boris.112444
Date of Publication
April 2018
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Contributor
Pfortmüller, Carmen
Universitätsklinik für Intensivmedizin
Kabon, Barbara
Schefold, Jörg Christian
Universitätsklinik für Intensivmedizin
Fleischmann, Edith
Subject(s)

600 - Technology::610...

Series
Wiener klinische Wochenschrift
ISSN or ISBN (if monograph)
0043-5325
Publisher
Springer
Language
English
Publisher DOI
10.1007/s00508-018-1327-y
PubMed ID
29500723
Uncontrolled Keywords

Acetate Balanced crys...

Description
Intravenous infusion of crystalloid solutions is one of the most frequently administered medications worldwide. Available crystalloid infusion solutions have a variety of compositions and have a major impact on body systems; however, administration of crystalloid fluids currently follows a "one fluid for all" approach than a patient-centered fluid prescription. Normal saline is associated with hyperchloremic metabolic acidosis, increased rates of acute kidney injury, increased hemodynamic instability and potentially mortality. Regarding balanced infusates, evidence remains less clear since most studies compared normal saline to buffered infusion solutes.; however, buffered solutes are not homogeneous. The term "buffered solutes" only refers to the concept of acid-buffering in infusion fluids but this does not necessarily imply that the solutes have similar physiological impacts. The currently available data indicate that balanced infusates might have some advantages; however, evidence still is inconclusive. Taking the available evidence together, there is no single fluid that is superior for all patients and settings, because all currently available infusates have distinct differences, advantages and disadvantages; therefore, it seems inevitable to abandon the "one fluid for all" strategy towards a more differentiated and patient-centered approach to fluid therapy in the critically ill.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/159087
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
2018 - Pfortmüller - Wien Klin Wochenschr - PMID 29500723.pdftextAdobe PDF521.08 KBpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 27ad28 [15.10. 15:21]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo